Logo for Amylyx Pharmaceuticals Inc

Amylyx Pharmaceuticals Investor Relations Material

Latest events

Logo for Amylyx Pharmaceuticals Inc

Q3 2024

Amylyx Pharmaceuticals
Logo for Amylyx Pharmaceuticals

Q3 2024

7 Nov, 2024
Logo for Amylyx Pharmaceuticals

Study Result

17 Oct, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Amylyx Pharmaceuticals Inc

Access all reports
Amylyx Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing treatments for neurodegenerative diseases. The company's research and product development primarily target conditions such as amyotrophic lateral sclerosis (ALS) and other neurodegenerative disorders, aiming to slow disease progression and improve patient outcomes. Amylyx leverages its scientific expertise in neurobiology to create therapies that address the underlying mechanisms of these diseases. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.